Matt Hewitt
Stock Analyst at Craig-Hallum
(3.83)
# 1,924
Out of 4,476 analysts
818
Total ratings
48%
Success rate
4.1%
Average return
Main Sectors:
Stocks Rated by Matt Hewitt
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MXCT MaxCyte | Maintained: Buy | n/a | $1.22 | - | 36 | Jul 2, 2026 | |
| LGND Ligand Pharmaceuticals | Maintained: Buy | n/a | $319.55 | - | 69 | Jul 1, 2026 | |
| SDGR Schrödinger | Maintained: Buy | n/a | $16.88 | - | 51 | Jun 30, 2026 | |
| CDXS Codexis | Maintained: Buy | n/a | $2.47 | - | 50 | Jun 25, 2026 | |
| RGEN Repligen | Maintained: Buy | n/a | $142.40 | - | 57 | Jun 24, 2026 | |
| BLFS BioLife Solutions | Maintained: Buy | n/a | $28.11 | - | 34 | Jun 24, 2026 | |
| CYRX Cryoport | Maintained: Buy | n/a | $15.49 | - | 7 | Jun 24, 2026 | |
| TKNO Alpha Teknova | Maintained: Buy | n/a | $5.77 | - | 21 | Jun 24, 2026 | |
| SLP Simulations Plus | Downgraded: Hold | $19 | $18.39 | +0.60% | 52 | Jun 18, 2026 | |
| CERT Certara | Rated: Hold | n/a | $6.97 | - | 16 | Jun 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $5.09 | - | 38 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.9405 | - | 11 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $43.03 | - | 48 | Jun 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $2.87 | - | 18 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $4.91 | - | 2 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $21.10 | - | 6 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $10.16 | - | 20 | May 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $4.30 | +39.53% | 55 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $6.04 | -17.22% | 31 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $2.42 | +189.26% | 27 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $28.41 | +40.80% | 30 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1.34 | - | 1 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $106.03 | - | 1 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.011 | - | 37 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $5.76 | +108.33% | 20 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $2.80 | - | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $5.26 | - | 12 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $18.13 | n/a | 1 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $15.16 | n/a | 13 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $28.69 | n/a | 1 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $1.60 | n/a | 2 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $2.64 | n/a | 15 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $6 | $3.07 | n/a | 1 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $14.07 | n/a | 1 | Sep 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $9.20 | n/a | 22 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 → $17 | $13.05 | n/a | 2 | Oct 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $100 | $0.0002 | n/a | 1 | Jan 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $215 → $154 | $70.83 | n/a | 3 | Oct 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 | $3.95 | n/a | 4 | Feb 27, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $50 | $75.07 | n/a | 1 | Nov 8, 2017 |
MaxCyte
Jul 2, 2026
Maintained: Buy
Price Target: n/a
Current: $1.22
Upside: -
Ligand Pharmaceuticals
Jul 1, 2026
Maintained: Buy
Price Target: n/a
Current: $319.55
Upside: -
Schrödinger
Jun 30, 2026
Maintained: Buy
Price Target: n/a
Current: $16.88
Upside: -
Codexis
Jun 25, 2026
Maintained: Buy
Price Target: n/a
Current: $2.47
Upside: -
Repligen
Jun 24, 2026
Maintained: Buy
Price Target: n/a
Current: $142.40
Upside: -
BioLife Solutions
Jun 24, 2026
Maintained: Buy
Price Target: n/a
Current: $28.11
Upside: -
Cryoport
Jun 24, 2026
Maintained: Buy
Price Target: n/a
Current: $15.49
Upside: -
Alpha Teknova
Jun 24, 2026
Maintained: Buy
Price Target: n/a
Current: $5.77
Upside: -
Simulations Plus
Jun 18, 2026
Downgraded: Hold
Price Target: $19
Current: $18.39
Upside: +0.60%
Certara
Jun 18, 2026
Rated: Hold
Price Target: n/a
Current: $6.97
Upside: -
Jun 15, 2026
Maintained: Buy
Price Target: n/a
Current: $5.09
Upside: -
Jun 15, 2026
Maintained: Buy
Price Target: n/a
Current: $0.9405
Upside: -
Jun 11, 2026
Maintained: Buy
Price Target: n/a
Current: $43.03
Upside: -
Jun 8, 2026
Maintained: Buy
Price Target: n/a
Current: $2.87
Upside: -
Jun 2, 2026
Maintained: Hold
Price Target: n/a
Current: $4.91
Upside: -
Jun 2, 2026
Maintained: Buy
Price Target: n/a
Current: $21.10
Upside: -
May 19, 2026
Maintained: Buy
Price Target: n/a
Current: $10.16
Upside: -
May 8, 2026
Reiterated: Buy
Price Target: $6
Current: $4.30
Upside: +39.53%
May 8, 2026
Reiterated: Buy
Price Target: $5
Current: $6.04
Upside: -17.22%
May 8, 2026
Reiterated: Buy
Price Target: $7
Current: $2.42
Upside: +189.26%
May 6, 2026
Reiterated: Buy
Price Target: $40
Current: $28.41
Upside: +40.80%
Mar 25, 2026
Maintained: Buy
Price Target: n/a
Current: $1.34
Upside: -
Feb 23, 2026
Maintained: Buy
Price Target: n/a
Current: $106.03
Upside: -
Feb 6, 2026
Maintained: Buy
Price Target: n/a
Current: $0.011
Upside: -
Dec 16, 2025
Maintained: Buy
Price Target: $12
Current: $5.76
Upside: +108.33%
Dec 9, 2025
Maintained: Buy
Price Target: n/a
Current: $2.80
Upside: -
Oct 10, 2025
Maintained: Buy
Price Target: n/a
Current: $5.26
Upside: -
Jun 17, 2025
Rated: Hold
Price Target: n/a
Current: $18.13
Upside: n/a
Apr 25, 2025
Maintained: Buy
Price Target: n/a
Current: $15.16
Upside: n/a
Mar 18, 2025
Maintained: Buy
Price Target: n/a
Current: $28.69
Upside: n/a
Dec 18, 2024
Rated: Buy
Price Target: n/a
Current: $1.60
Upside: n/a
Aug 7, 2024
Maintained: Buy
Price Target: n/a
Current: $2.64
Upside: n/a
Feb 9, 2024
Rated: Buy
Price Target: $6
Current: $3.07
Upside: n/a
Sep 21, 2023
Maintained: Buy
Price Target: n/a
Current: $14.07
Upside: n/a
Feb 23, 2023
Rated: Hold
Price Target: n/a
Current: $9.20
Upside: n/a
Oct 4, 2019
Reiterated: Hold
Price Target: $16 → $17
Current: $13.05
Upside: n/a
Jan 18, 2019
Maintained: Hold
Price Target: $100
Current: $0.0002
Upside: n/a
Oct 31, 2018
Downgraded: Hold
Price Target: $215 → $154
Current: $70.83
Upside: n/a
Feb 27, 2018
Maintained: Buy
Price Target: $19
Current: $3.95
Upside: n/a
Nov 8, 2017
Reiterated: Hold
Price Target: $50
Current: $75.07
Upside: n/a